New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis

Bibliography

• Polman CH, Reingold SC, Edan G, Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6
   PubMed Web of Science ®Google Scholar
• Fisniku LK, Brex PA, Altmann DR, Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;131:808-17
   PubMed Web of Science ®Google Scholar
• Simon JH, Li D, Traboulsee A, Standardized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines. AJNR Am J Neuroradiol 2006;27:455-61
   PubMed Web of Science ®Google Scholar
• Lovblad KO, Anzalone N, Dorfler A, MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am J Neuroradiol 2010;31:983-9
   PubMed Web of Science ®Google Scholar
• Bakshi R, Thompson AJ, Rocca MA, MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615-25
   PubMed Web of Science ®Google Scholar
• Giorgio A, Battaglini M, Smith SM, Brain atrophy assessment in multiple sclerosis: importance and limitations. Neuroimaging Clin N Am 2008;18:675-86; xi
   PubMed Web of Science ®Google Scholar
• Ropele S, Fazekas F. Magnetization transfer MR imaging in multiple sclerosis. Neuroimaging Clin N Am 2009;19:27-36
   PubMed Web of Science ®Google Scholar
• Rovaris M, Agosta F, Pagani E, Diffusion tensor MR imaging. Neuroimaging Clin N Am 2009;19:37-43
   PubMed Web of Science ®Google Scholar
• Sajja BR, Wolinsky JS, Narayana PA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2009;19:45-58
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA. Functional MR imaging in multiple sclerosis. Neuroimaging Clin N Am 2009;19:59-70
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95
   PubMed Web of Science ®Google Scholar
• Ormerod IE, Miller DH, McDonald WI, The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 1987;110(Pt 6):1579-616
   PubMedGoogle Scholar
• Filippi M, Gawne-Cain ML, Gasperini C, Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 1998;50:238-44
   PubMed Web of Science ®Google Scholar
• Barkhof F, Filippi M, van Waesberghe JH, Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 1997;49:1682-8
   PubMed Web of Science ®Google Scholar
• Lycklama G, Thompson A, Filippi M, Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003;2:555-62
   PubMed Web of Science ®Google Scholar
• Miller DH, Newton MR, van der Poel JC, Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38:175-9
   PubMed Web of Science ®Google Scholar
• Davies MB, Williams R, Haq N, MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998;40:765-70
   PubMed Web of Science ®Google Scholar
• Rocca MA, Hickman SJ, Bo L, Imaging the optic nerve in multiple sclerosis. Mult Scler 2005;11:537-41
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7
   PubMed Web of Science ®Google Scholar
• Barkhof F, Filippi M, Miller DH, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(Pt 11):2059-69
   PubMed Web of Science ®Google Scholar
• Tintore M, Rovira A, Martinez MJ, Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21:702-6
   PubMed Web of Science ®Google Scholar
• Tintore M, Rovira A, Rio J, New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003;60:27-30
   PubMed Web of Science ®Google Scholar
• Swanton JK, Fernando K, Dalton CM, Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830-3
   PubMed Web of Science ®Google Scholar
• Swanton JK, Rovira A, Tintore M, MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:677-86
   PubMed Web of Science ®Google Scholar
• Rovira A, Swanton J, Tintore M, A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 2009;66:587-92
   PubMed Web of Science ®Google Scholar
• Montalban X, Tintore M, Swanton J, MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74:427-34
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302
   PubMed Web of Science ®Google Scholar
• Charil A, Yousry TA, Rovaris M, MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 2006;5:841-52
   PubMed Web of Science ®Google Scholar
• Miller DH, Weinshenker BG, Filippi M, Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008;14:1157-74
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9
   PubMed Web of Science ®Google Scholar
• Filippi M, Horsfield MA, Morrissey SP, Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635-41
   PubMed Web of Science ®Google Scholar
• Brex PA, Ciccarelli O, O'Riordan JI, A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-64
   PubMed Web of Science ®Google Scholar
• Minneboo A, Barkhof F, Polman CH, Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004;61:217-21
   PubMed Web of Science ®Google Scholar
• Rocca MA, Agosta F, Sormani MP, A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008;255:683-91
   PubMed Web of Science ®Google Scholar
• Tintore M, Rovira A, Rio J, Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 2006;67:968-72
   PubMed Web of Science ®Google Scholar
• Swanton JK, Fernando KT, Dalton CM, Early MRI in optic neuritis: the risk for disability. Neurology 2009;72:542-50
   PubMed Web of Science ®Google Scholar
• Summers M, Fisniku L, Anderson V, Cognitive impairment in relapsing-remitting multiple sclerosis can be predicted by imaging performed several years earlier. Mult Scler 2008;14:197-204
   PubMed Web of Science ®Google Scholar
• Lucchinetti CF, Popescu BFG, Bunyan RF, Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-97
   PubMed Web of Science ®Google Scholar
• Geurts JJ, Pouwels PJ, Uitdehaag BM, Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-60
   PubMed Web of Science ®Google Scholar
• Calabrese M, De Stefano N, Atzori M, Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007;64:1416-22
   PubMedGoogle Scholar
• Filippi M, Rocca MA, Calabrese M, Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010;75:1988-94
   PubMed Web of Science ®Google Scholar
• Fernando KT, Tozer DJ, Miszkiel KA, Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005;128:2911-25
   PubMed Web of Science ®Google Scholar
• Iannucci G, Tortorella C, Rovaris M, Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000;21:1034-8
   PubMed Web of Science ®Google Scholar
• Ranjeva JP, Audoin B, Au Duong MV, Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 2005;26:119-27
   PubMed Web of Science ®Google Scholar
• Gallo A, Rovaris M, Benedetti B, A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. J Neurol 2007;254:78-83
   PubMed Web of Science ®Google Scholar
• Gallo A, Rovaris M, Riva R, Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005;62:803-8
   PubMed Web of Science ®Google Scholar
• Raz E, Cercignani M, Sbardella E, Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010;254:227-34
   Google Scholar
• Pagani E, Filippi M, Rocca MA, A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2005;26:258-65
   PubMed Web of Science ®Google Scholar
• Ciccarelli O, Toosy AT, Hickman SJ, Optic radiation changes after optic neuritis detected by tractography-based group mapping. Hum Brain Mapp 2005;25:308-16
   PubMed Web of Science ®Google Scholar
• Filippi M, Bozzali M, Rovaris M, Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003;126:433-7
   PubMed Web of Science ®Google Scholar
• Rovaris M, Gallo A, Falini A, Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Arch Neurol 2005;62:898-902
   PubMed Web of Science ®Google Scholar
• Pulizzi A, Rovaris M, Judica E, Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Arch Neurol 2007;64:1163-8
   PubMed Web of Science ®Google Scholar
• Fernando KT, McLean MA, Chard DT, Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361-9
   PubMed Web of Science ®Google Scholar
• Kapeller P, Brex PA, Chard D, Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002;8:207-10
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Harzheim M, Lutterbey GG, Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 2008;50:123-9
   PubMed Web of Science ®Google Scholar
• Audoin B, Ranjeva JP, Au Duong MV, Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis. J Magn Reson Imaging 2004;20:765-71
   PubMed Web of Science ®Google Scholar
• Khalil M, Enzinger C, Langkammer C, Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome. Mult Scler 2011;17:173-80
   PubMed Web of Science ®Google Scholar
• Audoin B, Fernando KT, Swanton JK, Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. Brain 2006;129:1031-9
   PubMed Web of Science ®Google Scholar
• Rovaris M, Judica E, Ceccarelli A, A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008;255:1209-14
   PubMed Web of Science ®Google Scholar
• Ceccarelli A, Filippi M, Neema M, T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler 2009;15:678-86
   PubMed Web of Science ®Google Scholar
• Brex PA, Jenkins R, Fox NC, Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000;54:1689-91
   PubMed Web of Science ®Google Scholar
• Dalton CM, Brex PA, Jenkins R, Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;73:141-7
   PubMed Web of Science ®Google Scholar
• Dalton CM, Chard DT, Davies GR, Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-7
   PubMed Web of Science ®Google Scholar
• Ceccarelli A, Rocca MA, Pagani E, A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42:315-22
   Google Scholar
• Henry RG, Shieh M, Okuda DT, Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008;79:1236-44
   PubMed Web of Science ®Google Scholar
• Raz E, Cercignani M, Sbardella E, Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010;257:448-54
   PubMed Web of Science ®Google Scholar
• Rocca MA, Mezzapesa DM, Falini A, Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2003;18:847-55
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Mezzapesa DM, Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Hum Brain Mapp 2004;21:108-17
   PubMed Web of Science ®Google Scholar
• Audoin B, Ibarrola D, Ranjeva JP, Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp 2003;20:51-8
   PubMed Web of Science ®Google Scholar
• Forn C, Rocca M, Valsasina P, Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study. Mult Scler 2011; DOI: 10.1177/1352458511417744
   PubMed Web of Science ®Google Scholar
• Rocca MA, Mezzapesa DM, Ghezzi A, A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. AJNR Am J Neuroradiol 2005;26:1136-9
   PubMed Web of Science ®Google Scholar
• Audoin B, Reuter F, Duong MV, Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study. Mult Scler 2008;14:786-92
   PubMed Web of Science ®Google Scholar
• Sicotte NL, Voskuhl RR, Bouvier S, Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol 2003;38:423-7
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Lutterbey GG, Harzheim M, Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol 2006;16:2067-73
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Lutterbey GG, Gieseke J, Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol 2007;28:54-9
   PubMed Web of Science ®Google Scholar
• Wattjes MP, Harzheim M, Lutterbey GG, Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol 2008;255:1159-63
   PubMed Web of Science ®Google Scholar
• Hammond KE, Metcalf M, Carvajal L, Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008;64:707-13
   PubMed Web of Science ®Google Scholar
• Mainero C, Benner T, Radding A, In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009;73:941-8
   PubMed Web of Science ®Google Scholar
• Kangarlu A, Bourekas EC, Ray-Chaudhury A, Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol 2007;28:262-6
   PubMed Web of Science ®Google Scholar
• Kollia K, Maderwald S, Putzki N, First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009;30:699-702
   PubMed Web of Science ®Google Scholar
• Cohen-Adad J, Benner T, Greve D, In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 2011;57:55-62
   Google Scholar
• The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-85
   PubMed Web of Science ®Google Scholar
• Comi G, Filippi M, Barkhof F, Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001;357:1576-82
   PubMed Web of Science ®Google Scholar
• Comi G, Martinelli V, Rodegher M, Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 2009;374:1503-11
   PubMed Web of Science ®Google Scholar
• Kappos L, Freedman MS, Polman CH, Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 2009;8:987-97
   PubMed Web of Science ®Google Scholar